Skip to main content
Charles Brummitt, MD, Infectious Disease, Milwaukee, WI, Aurora St. Luke's Medical Center

CharlesFBrummittMDFACP

Infectious Disease • Milwaukee, WI

Co-chair Antimicrobial Stewardship Program, AdvocateAurora Health. Head, Section of Infectious Diseases, Aurora St Lukes Medical Center.

Join to view full profile

Dr. Brummitt is on Doximity

As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.

  • Connect with other colleagues in the same hospital or clinic
  • Search all U.S. specialist profiles and refer a patient
  • Read the latest clinical news and earn CME/CEU credits

See Dr. Brummitt's full profile

Already have an account?

Summary

  • Dr. Charles Brummitt is an infectious disease specialist in Milwaukee, WI at Aurora St. Luke's Medical Center. He received his medical degree from University of Wisconsin School of Medicine and Public Health and has been in practice 35 years. He is experienced in hiv/aids, epidemiology, and antibiotic stewardship.

Education & Training

  • University of Minnesota
    University of MinnesotaFellowship, Infectious Disease, 1985 - 1988
  • University of Minnesota
    University of MinnesotaResidency, Internal Medicine, 1983 - 1985
  • University of Minnesota
    University of MinnesotaInternship, Internal Medicine, 1982 - 1983
  • University of Wisconsin School of Medicine & Public Health
    University of Wisconsin School of Medicine & Public HealthClass of 1982
  • University of Wisconsin
    University of WisconsinB.S, 1978

Certifications & Licensure

  • WI State Medical License
    WI State Medical License 1986 - 2023
  • MN State Medical License
    MN State Medical License 1983 - 1988
  • American Board of Internal Medicine Internal Medicine
  • American Board of Internal Medicine Infectious Disease

Awards, Honors, & Recognition

  • Top Doctor
  • Best Doctors in America
  • Super Doctor SuperDoctors.com
  • Join now to see all

Publications & Presentations

PubMed

Journal Articles

  • Treatment with Lamivudine, Zidovudine, or both in HIV-positive patients with 200 to 500 CD4+ cells per cubic millimeter.  
    Eron, J.J., Benoit, S. L., Jemsek, J., MacArthur, R.D., Santana, J., Quinn, J.B., Kuritzkes, D.R., Fallon, M.A., Rubin, M, New Engl J Med 333:1662-69
  • Lamivudine plus Zidovudine compared with Zalcitabine plus Zidovudine.  
    Bartlett, J.A. , Benoit, S.L., Johnson, V.A., Quinn, J.B., Sepulveda, G.E., Ehmann, W.C., Tsoukas, C., Fallon, M.A., Self, P.L., Rubin, M, Ann Intern Med 125:161-172
  • Fat not Fiction.  
    Brummitt, C. F, New Scientist 182 (2249):30

Books/Book Chapters

  • Monokines and other nonlymphocytic Cytokines. 
    Chapter: Beta-endorphin inhibits the release of interleukin-1 from stimulated peripheral blood mononuclear cells 
    Page 125 - 130Brummitt, C.F., Gekker, G., Sharp, B., Keane, W.F., and Peterson, P.KEditors: M. Powanda, J. Oppenheim, M. Kluger, C. Dinarello.Alan R. Liss, Inc, New York

Abstracts/Posters

  • Large common-source outbreak of adenovirus type 3 among hospital personnel.
    Van Drunen, M., Juni, B.A., Brummitt, C.F., Cameron, S. B., Cherrington, J., Edelman, C., and Katzenstein, D, 86th Annual Meeting, American Society for Microbiology
  • Opioid-mediated suppression of human mononuclear cell interferon-production.
    Brummitt, C.F., Sharp, B., Gekker, G., Keane, W.F., and Peterson, P.K, Clin Res 35:469A, Federation for Clinical Research
  • Beta-endorphin inhibits interleukin-1 release by cultured peripheral blood mononuclear cells.
    Brummitt, C.F., Sharp, B., Gekker, G., Keane, W.F., and Peterson, P.K, First International Workshop on Monokines and Non-lymphocytic Cytokines
  • Join now to see all

Press Mentions

  • How to Avoid Misusing Antibiotics
    How to Avoid Misusing AntibioticsAugust 19th, 2019

Hospital Affiliations

Dr. Charles Brummitt, Dr. Charles Brummitt, MD, Dr. C Brummitt, Dr. Charles F Brummitt